News

Neuralstem has received a patent allowance from the US Patent and Trademark Office (USPTO) for several compounds that can help grow new neurons. Patent application 12/049,922, entitled Use

Novartis has announced that the Novartis Vaccines Institute for Global Health has been awarded a grant from the Wellcome Trust to develop a bivalent vaccine for typhoid fever.

Abbott and AstraZeneca have announced the submission of a new drug application (NDA) to the US Food and Drug Administration (FDA). It is for an investigational compound for

The Indian medical equipments market is projected at INR57.5 with a growth rate of 23% expected in the coming years. The market for medical supplies and disposables is

Wyeth has received positive recommendations from the European Committee for Medicinal Products for Human Use (CHMP) for two recent submissions relating to Enbrel (etanercept). It’s a tumour necrosis

Synthetech has announced financial results for its fiscal fourth quarter and fiscal year, which ended March 31, 2009. For the fourth quarter ended March 31, 2009, revenue was

A patent appeals board had ruled in favor of Affymetrix, as did the U.S. District Court for the Northern District of California. But the U.S. Court of Appeals

Eli Lilly has resubmitted its supplemental New Drug Application (sNDA) for Cymbalta (duloxetine HCl) for the management of chronic pain, to the FDA. The resubmission is based on

CombiMatrix has announced that the validation study performed by its wholly-owned subsidiary, Combimatrix Molecular Diagnostics (CMDX), in collaboration with the Department of Pathology at the University of Texas